Cannabis Bioscience International Holdings, Inc.
corporate_fare Company Profile
Cannabis Bioscience International Holdings, Inc. (OTC:CBIH) is a publicly traded company in the Life Sciences sector. Wiseek monitors CBIH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- CBIH Signs First VitaCookies Licensing Deal, Initiating Commercial Rollout
- Cannabis Bioscience International Holdings Reports Near-Zero Cash, Worsening Financials, and Ineffective Controls Amidst Going Concern Warning
- Going Concern Warning, Ineffective Controls, and Deteriorating Financials Highlight Severe Risks
Financial Snapshot
Fiscal year ended May 31, 2025
Revenue
$303.02K
Net Income
-$548.82K
Diluted EPS
-$0.00
Op. Cash Flow
-$329.63K
Gross Profit
$262.92K
Operating Income
-$421.37K
Cash & Equivalents
$12.95K
Total Debt
$264.09K
Debt / Equity
-0.23×
Net Margin
-181.1%
Shares Outstanding
11.63B sh
Source: 10-K · filed 2025-09-22 · accession 0001683168-25-007174
show_chartPrice Chart
Loading chart...
feed CBIH - Latest Insights
CBIH
Jun 22, 2026, 7:00 AM EDT
Price at Filing:
$0.0003
Real-time Price:
$0.0002
Change:
-$0.0001 (-33%)
Market Cap:
$2.325M
CBIH
Apr 16, 2026, 3:39 PM EDT
Price at Filing:
$0.0004
Real-time Price:
$0.0002
Change:
-$0.0002 (-50%)
Market Cap:
$2.325M
CBIH
Feb 19, 2026, 4:11 PM EST
Price at Filing:
$0.0004
Real-time Price:
$0.0002
Change:
-$0.0002 (-50%)
Market Cap:
$2.325M